1.Previous
3.Next

Nonetheless, epilepsy management in the ID population can be challenging due to high levels of polypharmacy prescribing, drug interactions, and increased vulnerability to adverse effects. It is thought that 70% of individuals with ID are pharmaco-resistant, however only about 10% of individuals are prescribed anti-seizure medications (ASMs) licensed for pharmaco-resistant epilepsy.

1.Previous
3.Next